Schliengen, Germany

Ingrid Heinze-Krauss

This inventor holds 8 USPTO granted patents. Top assignees: Hoffmann-La Roche Inc., Basilea Pharmaceutica Ag. Active years: 1998-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ingrid Heinze-Krauss. Retrieved from https://idiyas.com/inventor/ingrid-heinze-krauss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 1998-2003

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ingrid Heinze-Krauss

Introduction

Ingrid Heinze-Krauss is a prominent inventor based in Schliengen, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporin derivatives. With a total of 8 patents to her name, her work has had a substantial impact on medical science.

Latest Patents

Among her latest patents are innovative compounds such as propenyl cephalosporin derivatives and vinylpyrrolidinone cephalosporin derivatives. These inventions relate to cephalosporin derivatives of a general formula, showcasing her expertise in pharmaceutical chemistry.

Career Highlights

Throughout her career, Ingrid has worked with notable companies, including Hoffmann-La Roche Inc. and Basilea Pharmaceutica AG. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Ingrid has collaborated with esteemed colleagues such as Peter Angehrn and Malcolm Page. These partnerships have further enhanced her research and development efforts, leading to innovative solutions in her field.

Conclusion

Ingrid Heinze-Krauss is a remarkable inventor whose work in cephalosporin derivatives has advanced pharmaceutical science. Her contributions continue to influence the industry and inspire future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…